Stipple Bio, Inc. — Form D
Stipple Bio, Inc. of Cambridge, MA, a company, filed a Form D exempt-offering notice with the SEC on 2022-06-07. The offering totals $12.0M, of which $12.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2022-06-07
- Form: D
- Accession: 0001932776-22-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $12.0M
- Amount sold: $12.0M
- Remaining: $25K
- Investors: 7
- Date of first sale: 2022-05-31
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-448308
Issuer
- Name: Stipple Bio, Inc.
- CIK: 0001932776
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 238 Main Street Suite 101, Cambridge, MA, 02142
- Phone: (646) 248-0890
Officers, directors & promoters (13)
| Name | Role | Location |
|---|
| Vineeta Agarwala | Director | Menlo Park, CA |
| Vineeta Agarwala | Related Person | Menlo Park, CA |
| Owen Hughes | Director | Sudbury, MA |
| Owen Hughes | Related Person | Sudbury, MA |
| Aaron Ring | Director | Cambridge, MA |
| Aaron Ring | Executive Officer | Cambridge, MA |
| Aaron Ring | Related Person | Cambridge, MA |
| Derek DiRocco | Related Person | Boston, MA |
| Antoine Yver | Director | Rocky Hill, NJ |
| Greg Verdine | Director | Boston, MA |
| Greg Verdine | Related Person | Boston, MA |
| Thilo Schroeder | Related Person | Grand Duchy of Luxembourg, N4 |
| Jeffrey Landau | Related Person | Cambridge, MA |
Other filings by this issuer (2)
More